
|Articles|April 21, 2015
AJPB® Translating Evidence-Based Research Into Value-Based Decisions®
- March/April 2015
- Volume 7
- Issue 2
Web Exclusives Coming Soon
Advertisement
Articles in this issue
over 10 years ago
Sinking the Titanicover 10 years ago
What Patients Want and Need From Health Exchange Plansover 10 years ago
Medicare Plans Face New Oversight and Scrutiny From Audit ChangesNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Addressing Drug Resistance in Lung Cancer
2
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
3
From Mutation to Medicine: Targeted Therapies in Lung Cancer
4
Tar-200 Plus Anti–PD-1 Therapy Shows Promising Neoadjuvant Activity in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
5